Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Tissue Regen 2020

About Conference

Join us for 11th Tissue Science and Regeneration Congress

Update your skills, enhance your knowledge base, and broaden your horizons- all in one place!

Date: April 20-21, 2020

Venue: Kuala Lumpur, Malaysia

If you are interested to be a part of this event as a speaker or delegate!

Email at: [email protected]

Call at: 1-201-380-5561 (Extension No- 7007)

WhatsApp at: +44 7723584563

We cordially welcome all the interested participants to our upcoming 11th Tissue Science and Regeneration Congress  which is going to be held during April 20-21, 2020 at Kuala Lumpur, Malaysia. This includes a wide range of Keynote presentations, plenary talks, Symposia, Workshops, Exhibitions, Poster presentations.

Tissue Regen 2020  will discuss various disciplines involved in the pre-clinical research, conduct of Tissue Science & Regenerative medicine. It will educate health care researchers about design, operation, organizing, research computing, regulatory aspects and reporting of Biomedical Engineering. It promotes better understanding by the general public about the importance of Tissue Engineering, Regenerative medicine in prevention, diagnosis and treatment of disease. This conference conduct presentations, distribute information, meet with current and potential scientists, make a splash with new Tissue engineering, Regenerative medicine, Bio banking, Tissue culture and preservation, Stem cell Therapy research developments, and receive name recognition at this 2-days event. World renowned speakers and the most recent techniques, developments, the newest updates in Tissue Science, Regenerative medicine Research are hallmarks of this conference.

Why to Attend Tissue Regen 2020 ?

11th Tissue Science and Regeneration Congress have the platform to fulfil the needs in the transformation of this science of hope, to serve promptly with solutions to all the needs. Tissue Regen 2020 will have participants across the world to discuss the Congress goal.

About Organizers

ME Conferences is one of the leading Open Access publishers and organizers of international scientific conferences and events every year across USA, Europe & Asia. Conference Series has so far organized 3000+ Global  Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business with 700+ peer-reviewed open access journals in basic science, health, and technology.

Target Audience


Scientific Sessions of Tissue Regen Conference:

Tissue Regen 2020 will encompass recent researches and findings in Tissue science and Regeneration technologies, stem cell therapies and transplantations and other advancements in stem cell research and Tissue science. Tissue Regen 2020 will be a great platform for research scientists and young researchers to share their current findings in this field of applied science. The major scientific sessions in Tissue Regen 2020 will focus on the latest and exciting innovations in prominent areas of Tissue science and stem cell research.

Track 1: Tissue Science

Tissue is a cellular organisational level between cells and a complete organ. A tissue is an ensemble of similar cells and their extracellular matrix from the same origin that together carry out a specific function. Organs are then formed by the functional grouping together of multiple tissues. Tissue used for research can be called many different things: specimen, biological samples or human biological material. All of these terms refer to a small piece or sample of tissue or fluid and are used interchangeably. When researchers say tissue they can mean blood, urine, saliva, feces, fluid from the spine and brain, organ tissue, bone marrow, tumor tissue, lymph nodes, lymphatic fluid, and many others.

Track 2: Regenerative Medicine

Regenerative Medicine goes for helping the body to shape new tissue to replace lost ones.  This will give curative treatment to conditions .The human body has an endogenous arrangement of recovery through foundational microorganisms, where undeveloped cells are discovered nearly in every kind of tissue. The thought is that upgrading of capacity is best proficient by these cells. Regenerative prescription involves the utilization of tissue designing and undifferentiated organism innovation.

Track 3: Cellular and Gene Therapies

Cellular therapy (CT) is the transplantation of human cells to replace or repair damaged tissue and/or cells. With new technologies, innovative products, and limitless imagination, many different types of cells may be used as part of a therapy or treatment for a variety of diseases and conditions.  Some of the cells that may be used include hematopoietic (blood-forming) stem cells (HSC), skeletal muscle stem cells, mesenchymal stem cells, lymphocytes, dendritic cells, and pancreatic islet cells. It is used to treat a variety of blood cancers and hematologic conditions.

Gene therapy is the introduction, removal, or change in the content of a person’s genetic code with the goal of treating a disease, and hereditary diseases in which a defective mutant allele is replaced with a functional one. The transferred genetic material changes how a single protein or group of proteins is produced by the cell. Gene therapy can be used to reduce levels of a disease-causing version of a protein, increase production of disease-fighting proteins, or to produce new/modified proteins. 

Track 4: Stem Cell Therapy

Stem cell therapy is the use of stem cells to treat disease. It is the treatment of various disorders, non-serious to life threatening, by using stem cells. These stem cells can be procured from a lot of different sources and used to potentially treat more than 80 disorders, including neuromuscular and degenerative disorders. Bone marrow transplantation is the most used stem-cell therapy, but some therapies derived from Umbilical cord blood are also in use. Research is proceeding to develop various sources for stem cells and to put on stem-cell treatments for Neurogenerative disease and conditions such as diabetes, heart disease, and other conditions. Stem-cell therapy has become controversial following developments such as the ability of scientists to isolate and culture embryonic stem cell to create stem cells using somatic nuclear transfer and their use of techniques to create Induced pluripotent stem cell.

Track 5: Biomedicine

Biomedical engineering is the application of the principles and problem-solving techniques of engineering to biology and medicine. This is evident throughout healthcare, from diagnosis and analysis to treatment and recovery, and has entered the public conscience though the proliferation of implantable medical devices, such as pacemakers and artificial hips, to more futuristic technologies such as stem cell engineering and the 3-D printing of biological organs. Biomedical engineering prominence's on the developments that surge the human health and health care at all levels. Biomedical Engineering also referred to as Bioengineering, BioMed or BME, is a multidisciplinary STEM field that combines biology and engineering, applying engineering principles and materials to medicine and healthcare.

Track 6: Biomaterials & Bioengineering

Biomaterials are being used for the healthcare applications from ancient times. But subsequent evolution has made them more versatile and has increased their utility. Biomaterials have revolutionized the areas like bioengineering and tissue engineering for the development of novel strategies to combat life threatening diseases. Together with biomaterials, stem cell technology is also being used to improve the existing healthcare facilities. These concepts and technologies are being used for the treatment of different diseases like cardiac failure, fractures, deep skin injuries, etc.

Tissue Engineering is addressed to create functional tissues which include cells, scaffolds, and bioactive molecules. It is the development of biological substitutes that maintains, improves or restores tissue functions resulting in sidestepping the problems associated with tissue damage. In the present, it is treated with transplants, mechanical devices or surgical reconstructions, these three medical therapies have saved and improved countless patients’ lives with few associated problems. For example, transplantation in organs shows limitations such as transplant rejections and lack of donor to cover all the worldwide demand. Mechanical devices are not capable of accomplishing all the functions related to the tissue and also the prevention of progressive deterioration in patients.  Thus it has informed that Tissue Engineering arises from the need to provide more definitive solutions to tissue repairs.

Track 7: Artificial Organs

Artificial organs that have been designed to be used as an alternative to transplants, which are always in short supply. Failure of human's vital organs leads to death unless a replacement is found. The replacement can either be a transplant from another person or an artificial man-made organ. Use of transplants has the disadvantage of a limited supply and problems with immunorejection. Tissue Engineers started working on artificial organs for transplantation into the patients. Tissue engineering based tissues could allow to regenerate the whole organ or even to produce several organs for the purpose of grafting’s. Recently researchers are working on this field to develop and provide the tissue engineered organs and tissues to overcome the scarcity of the organs for transplants. 

Track 8: Anti-Aging and Functional Medicine

Stem cells are feasible to design and test interventions to slow aging and improve health and longevity. It is believed that stem cell failure contributes to a decline in health during aging; so the development of effective methods to induce and differentiate pluripotent stem cells via cell replacement therapy provides an exciting avenue for the treatment of degenerative age-related diseases. It is believed that the regenerative potential of these cells is due to their high differentiation and proliferation capabilities, paracrine activity and immune privilege. Therefore, the stem cells can be used for cell replacement therapy as a therapeutic intervention aimed at mitigating the effects of aging.

Track 9: Cancer Therapy

Tissue Engineering has evoked new hopes for the cure of failure of Organs and loss tissue by creating functional substitutes in laboratory. TE provides new technology platforms to study the mechanism of angiogenesis and tumour cell growth and potentially tumour spreading in cancer research. The synthesis of TE with innovative methods of molecular biology and stem-cell technology may help investigate and potentially modulate principal phenomena of tumour growth and spreading, as well as tumour-related angiogenesis. TE can be applied to cure the cancer in Breast, Skin, Melanoma, Bone, Prostate, Liver and brain.

Track 10: Wound Care

Wound is an injury involving an external or internal break in body tissue, usually involving the skin. It occurs when the skin is broken or damaged because of injury. Causes of injury may be the result of mechanical, chemical, electrical, thermal, or nuclear sources. The skin can be damaged in a variety of ways depending upon the mechanism of injury. Wounds fall into two broad categories: open or closed. In a closed wound, tissue damage and bleeding occur under the surface of the skin. Examples of closed wounds include bruises. An open wound involves a break in the skin that leaves the internal tissue exposed. Open wounds may result from falls, blunt trauma, and surgery.

Track 11: Bio Banking

Bio banking  is the process of storage of biological samples that can be a piece of human tissue taken from a healthy or a diseased part of the body, it can also be a sample of bodily fluid such as blood, urine or saliva. Tissue banking is the activity of processing, storage, and distribution of transplantable human tissues. Tissues retrieved from the human body are used to repair and or replace the diseased or lost tissues of living human body and have saved many precious lives. The common tissues used are cornea, skin, bones, cartilage, joints, heart valves, fascia, tendons and a human cadaver.

Track 12: Regenerative Rehabilitation

Regenerative rehabilitation is the values as of rehabilitation and regenerative medicine, with the ultimate goal of developing innovative and operative methods that promote the restoration of function through tissue regeneration and repair. In order to provide an optimal microenvironment for healing tissues, physical therapists use directed therapy to maximize the productivity of the body's innate healing processes. Rehabilitation coupled with regenerative medicine surgeries has shown improved outcomes for tissue regeneration. With innovative findings from medical researchers in tissue engineering and cellular therapies, physical therapies play an important role in translating these findings.

Track 13: Soft Tissue Replacement

In soft tissue implants, as in other applications that involve engineering, the performance of an implanted device depends upon both the materials used and the design of the device or implant. The initial selection of material should be based on sound materials engineering practice. The final judgment on the suitability of a material depends upon observation of the in-vivo clinical performance of the implant. This requirement of in-vivo observation represents one of the major problems in the selection of appropriate materials for use in the human body. Another problem is that the performance of an implant may also depend on the design rather than the materials themselves. Even though one may have an ideal material and design, the actual performance also greatly depends on the skill of the surgeons and the prior condition of patients. The success of soft tissue implants has primarily been due to the development of synthetic polymers. This is mainly because the polymers can be tailor-made to match the physical and chemical properties of soft tissues. 

Track 14: Nanotechnology in Tissue Engineering

Nanotechnology is currently being utilized for tissue engineering and regenerative medicine. Nanostructures can mimic tissue-specific bio environments by designing constructs with particular biochemical, mechanical and electrical properties. Biomimetic nanopatterns alone can direct the differentiation of stem cells without involvement of exogenous soluble biochemical factors. This regulation of cellular behavior by nanotechnology is one of many examples demonstrating the significant applications of nanoengineering in biomedicine.  Therefore, tissue can be engineered by employing these nanostructures for enhanced cell adhesion, growth and differentiation. As the range of tissues being proposed for engineering increases, there is also a proportional increase in demand for new scaffold properties.

Track 15: Stem Cell Therapies in Gynaecology

Stem cells as a new treatment modality for regenerative medicine, it involved in a new research effort and an increasing scientific interest in the field of stem cell-based therapy. We are therefore able to describe different areas in which stem cell research can be applied and developed in gynaecology. Hematopoietic stem cells have been used to set up therapeutic strategies for the treatment of gynaecological solid tumors such as ovarian cancer. Umbilical cord blood, which was often considered a waste material of the delivery, actually represents a precious source of stem cells that can be used for cell-based treatments of malignancies and inherited diseases. Feto-maternal cell traffic has recently been demonstrated through the placental barrier during pregnancy. This cellular exchange also includes stem cells from the fetus, which can generate microchimerisms in the mother and contribute to tissue repair mechanisms in different maternal organs. Stem cells can be used for prenatal transplantation to treat different severe congenital diseases of the fetus.


Market Analysis Report

Market Analysis of Tissue Science and Regeneration Congress

In Tissue Science, Regenerative medicines play a major role. Regenerative medicines have the ability to repair, replace, and regenerate tissues and organs affected due to injury, disease. These medicines are capable of restoring the functionality of cells & tissues and are applicable in a wide range of degenerative disorders developing number of surgeries fueled by maturing populace and rising injury cases are expected to move request for s tissue repair gadgets and in turn give development openings for manufacturers. In expansion, the expanding number of items propelled and industry solidification are anticipated to fortify the tissue repair showcase over the estimate period. For occurrence, presentation of organic unites by driving producers is picking up clutch. Organic joins diminish the recuperation period and have less difficulty   related to dismissal, which in turn is expected to boost request for these items over the estimate period. Developing number of patients enduring from sports related wounds is another calculate which is anticipated to advance tissue repair showcase development. Tissue  Engineering is an inter corrective field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ. Currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. 

Importance & Scope:

A innovative set of tissue replacement parts and implementation strategies had shown a great uprising in Tissue engineering   field. Cells placed on or within the tissue constructs is the most common methodology in tissue engineering. Regenerative medicine is not one discipline. It can be defined as a therapeutic intervention which “replaces or regenerates human cells, tissues or organs, to restore or establish normal function” and deploys small molecule drugs, biologics, medical devices and cell-based therapies. Regenerative Medicine-2015 is an captivated a locality of conscious discussions on novel subjects like Tissue Regeneration, Materials & Designs for Tissue Engineering, Stem Cell–Tools to Battle Cancer, Bioreactors in Tissue Engineering, Regeneration & Therapeutics, Cord Blood & Regenerative Medicine and Clinical Medicine. The two days event embeds a firm relation of upcoming strategies in the field of Tissue Repair & Regeneration with the scientific community. The theoretical and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations. We bring together business, creative, and technology leaders from the tissue engineering, marketing, and research industry for the most current and relevant.


Glimpse at Market of Regenerative Medicine:

There are strong pricing pressures from public healthcare payers globally as Governments try to reduce budget deficits. Regenerative medicine could possibly save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole. The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion to 2024.The contribution of the European region was 43.3% of the market in 2010, a value of $24.2 billion. The market is expected to reach $25.5 billion by 2011 and will further grow to $36.1 billion by 2016 at a CAGR of 7.2%. It grows to $65 billion to 2024.

The growing rate of Cell Therapy, TE, Gene Therapy and Small molecules over the Years:

Global data about Stem cell therapy, TE and Gene Therapy:

Target Audience of Tissue Science:

Industry        40%

Academia     50%

Others          10%


List of Major Tissue Science Society Worldwide:




Past Conference Report

Tissue Repair 2019

The 10th International Tissue Repair and Regeneration Congress which was held during June 13-14, 2019 at Helsinki, Finland with the theme of “Explore the concept of Tissue Repair, Restore & Regeneration” received a spectacular response.

With the active participation and support of the Organizing Committee Members, Editorial Board Members and impressive presentations of all eminent scientists, talented researchers and young student community made this conference one of the most successful and productive events in ME Conferences.

The conference was initiated with a warm welcome note from our Honorable guests and followed by Keynote sessions. We would like to convey the great appreciation for Dr. Zaid Matti from Australasian Faculty of Musculoskeletal Medicine, New Zealand and Mirolyuba Simeonova Ilieva from University of Southern Denmark, Denmark the Honourable moderator for the conference who contributed a major part to the success of this event.

The highlights of the meeting were the enlightening keynote lectures from:

1. Joel Isaias Osorio Garcia, RegenerAge, USA

2. Kristine Freude, BrainStem, Denmark

3. Gianni Pertici, Industrie Biomediche Insubri SA, Switzerland

Tissue Repair 2019 would also like to thank the following speakers for their splendid presentations on their research.

Zaid Matti, Australasian Faculty of Musculoskeletal Medicine, New Zealand

Omid Panahi, Yeditepe University, Turkey

Purwati, Universitas Airlangga, Indonesia

Mirolyuba Simeonova Ilieva, University of Southern Denmark, Denmark

Orianne Domenge, University of Lyon, France

Claire Saucourt, CellProthera, France

Pamela Klecki, Karolinska Insitute, Sweden

We earnestly thank the Organizing Committee Members, Participants and Media Partners for their thoughtful presence and liberal support, without which the conference would not have reached the apex of success. Your response is our inspiration; recalling this maxim and seeing the triumph of Tissue Repair 2019, ME Conferences would like to announce the commencement of the "11th Tissue Science and Regeneration Congress" scheduled for April 20-21, 2020 in Kuala Lumpur, Malaysia.

We welcome all the eminent researchers, professors, students and delegate participants from worldwide to partake in this forthcoming gathering to witness invaluable scientific discussions and add to the future advancements in the field of Tissue Science and Regeneration.

Let us meet @ Tissue Regen 2020


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date April 20-21, 2020

Speaker Opportunity

Supported By

Journal of Tissue Science & Engineering Journal of Cell & Developmental Biology Journal of Stem Cell Research & Therapy Journal of Cell Science & Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


  • Ageing Extra Cellular Matrix
  • Allogeneic Stem Cell
  • Allografts
  • Alpha-smooth Muscle Actin
  • Amniotic Membrane Tissue
  • Antiapoptotic Genes
  • Articular Cartilage
  • Articular Cartilage Therapy
  • Articular Chondrocytes
  • Bioactive Factors
  • Bioartificial Skin
  • Biocompatible Tissue
  • Biofilm
  • Biological Lubricant
  • Biomaterials
  • Biphasic Scaffold
  • Bladder Acellular Matrix Graft
  • Bone Marrow Cells
  • Bone Regeneration
  • Cartilage Engineering
  • Cell Culture
  • Cell Lineages
  • Cell-matrix
  • Chronic Wounds.
  • Collagen
  • Collagen Biosynthesi
  • Collagen Microspheres
  • Cord Versus Nodule
  • Distal Femur
  • Dormant Pluripotent
  • Electrohydrodynamic
  • Extracellular Matrix
  • Fetal Tissues
  • Fibrin
  • Fibroblast
  • Fibrocartilage
  • Fibrogenesis
  • Fibronectin
  • Fibroproliferative
  • Fibrotic Diseases
  • Fibrotic Tissue
  • Genetic Techniques
  • Green Fluorescent Protein
  • Growth Factors
  • Hepatic Fibrosis
  • Hepatic Stellate Cell
  • Human Dermal Fibroblasts
  • Hybrid Scaffolds
  • Idiopathic Pulmonary Fibrosis
  • Immunity
  • Implantation Strategies
  • Inflammatory Cell Types
  • Inflammatory Cytokine
  • Keratinocytes
  • Labile Tissues
  • Matrix Metalloproteases
  • Matrix Synthesis
  • Mesenchymal Progenitor Cells
  • Microfilamentous Network
  • Myelofibrosis
  • Myeloid Metaplasi
  • Myofibroblasts
  • Nanomaterials
  • Nanoparticle
  • Nanotopography
  • Nerve Guidance Channel
  • Nerve Regeneration
  • Nerve Tissue
  • Neuroscience
  • Osteogenic
  • Osteomyelitis
  • Peripheral Nerve Repair
  • Profibrotic Cytokines
  • Proregenerative Extracellular Matrix
  • Proteoglycan
  • Proteoglycan Aggrecan
  • Prototyping System
  • Recapitulation
  • Regulatory Affairs
  • Scaffoldless Techniques
  • Scarring
  • Self-assembled Biomimetic Copolymer
  • Skeletal Tissues
  • Skin Fibrosis
  • Skin Reconstruction
  • Spinal Cord Injury
  • Stem Cells
  • Subchondral Bone
  • Synthetic Biocompatible Polymeric Materials
  • Synthetic Grafts
  • Synthetic Polymer
  • Systemic Sclerosis
  • Therapeutic Angiogenesis
  • Therapeutic Implications
  • Three Dimensional Scaffoled
  • Thrombocythaemia
  • Tissue Micro Mechanics
  • Tissue Repair
  • Vascular Endothelial Growth Factor
  • Vascularized Tissue
  • Wound Healing